Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is
known about brain metastases than cancer-related entities of similar incidence. Advances in …

Brain metastases are a very common manifestation of cancer that have historically been
approached as a single disease entity given the uniform association with poor clinical …

Patients with brain metastases are now eligible for a number of treatment options that are
increasingly likely to improve outcomes. Randomized, prospective trials are necessary to …

Brain metastases occur in almost one-third of adult patients with solid tumor malignancies
and lead to considerable patient morbidity and mortality. The rising incidence of brain …

The clinical management/understanding of brain metastases (BM) has changed
substantially in the last 5 years, with key advances and clinical trials highlighted in this …

Despite major therapeutic advances in the management of patients with systemic
malignancies, management of brain metastases remains a significant challenge. These …

The development of brain metastases occurs in 10–20% of all patients with cancer. Brain
metastases portend poor survival and contribute to increased cancer mortality and morbidity …

Brain metastases are the most frequent neurological complication of cancer and the most
common brain tumour type. Lung and breast cancers, and melanoma are responsible for up …

Abstract BRAIN METASTASES CONTINUE to be a major and growing challenge in
oncology, but recent advances in surgery, radiosurgery, and chemotherapy have broadened …

Brain metastases (BM) occur in 20–40% of patients with cancer and 60–75% of patients with
BM become symptomatic. Due to an aging population and advances in the treatment of …